Weerasuria M, Ko C, Ehm A, O’Bryan J, McMahon J, Woolley I, et al. The impact of the COVID-19 pandemic on people living with HIV in Victoria, Australia. AIDS Res Hum Retroviruses. 2021;37(4):322–8.

Article  CAS  PubMed  Google Scholar 

Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, et al. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021;8(1):e24–32.

Article  CAS  PubMed  Google Scholar 

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamanaga S, Shimata K, Ohfuji S, Yoshikawa M, Natori Y, Hibi T, Yuzawa K, Egawa H. Japan Society for Transplantation COVID-19 Registry Study Group. Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic. Am J Transplant[Internet]. 2024. [Cited 2024 April 10]. Available from: https://www.amjtransplant.org/article/S1600-6135(24)00212-0/fulltext. https://doi.org/10.1016/j.ajt.2024.03.016. Epub ahead of print.

Griffin DWJ, Pai Mangalore R, Hoy JF, McMahon JH. Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV. AIDS. 2023;37(9):1345–60.

Article  CAS  PubMed  Google Scholar 

Petoumenos K, Huang R, Hoy J, Bloch M, Templeton DJ, Baker D, et al. Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES). PLoS ONE. 2017;12(9):e0184583.

Article  PubMed  PubMed Central  Google Scholar 

Antinori A, Cicalini S, Meschi S, Bordoni V, Lorenzini P, Vergori A, et al. Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count. Clin Infect Dis. 2022;75(1):e552–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kates OS, Haydel BM, Florman SS, Rana MM, Chaudhry ZS, Ramesh MS, et al. Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study. Clin Infect Dis. 2021;73(11):e4090–9.

Article  CAS  PubMed  Google Scholar 

Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325(21):2204–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hall VG, Al-Alahmadi G, Solera JT, Marinelli T, Cardinal H, Prasad GR, et al. Outcomes of SARS-CoV-2 infection in unvaccinated compared with vaccinated solid organ transplant recipients: a propensity matched cohort study. Transplantation. 2022;106(8):1622.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi SG, Moore LW, Eagar T, Graviss EA, Nguyen DT, Ibrahim H, et al. Risk factors associated with an impaired antibody response in kidney transplant recipients following 2 doses of the SARS-CoV-2 mRNA Vaccine. Transplantation Direct. 2022;8(1):e1257.

Article  CAS  PubMed  Google Scholar 

Ferreira VH, Solera JT, Hu Q, Hall VG, Arbol BG, Rod Hardy W, et al. Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings. Nat Commun. 2022;13(1):4489.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karaba AH, Zhou W, Li S, Aytenfisu TY, Johnston TS, Akinde O, et al. Impact of seasonal coronavirus antibodies on severe acute respiratory syndrome coronavirus 2 vaccine responses in solid organ transplant recipients. Clin Infect Dis. 2023;76(3):e495–8.

Article  CAS  PubMed  Google Scholar 

Karaba AH, Zhou W, Hsieh LL, Figueroa A, Massaccesi G, Rothman RE, et al. Differential cytokine signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza infection highlight key differences in pathobiology. Clin Infect Dis. 2022;74(2):254–62.

Article  CAS  PubMed  Google Scholar 

Marion O, Del Bello A, Abravanel F, Faguer S, Esposito L, Laure Hebral A, et al. Predictive factors for humoral response after 2-dose SARS-CoV-2 vaccine in solid organ transplant patients. Transplant Direct. 2022;8(1):e1248.

Article  CAS  PubMed  Google Scholar 

Shen Y, Freeman JA, Holland J, Solterbeck A, Naidu K, Soosapilla A, et al. COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity. Br J Haematol. 2022;197(1):41–51.

Article  CAS  PubMed  Google Scholar 

Lim SH, Stuart B, Joseph-Pietras D, Johnson M, Campbell N, Kelly A, et al. Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study. Nat Cancer. 2022;3(5):552–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sormani MP, Inglese M, Schiavetti I, Carmisciano L, Laroni A, Lapucci C, et al. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies. EBioMedicine. 2021;72:103581.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Australian Technical Advisory Group on Immunisation. Statement On The Administration Of COVID-19 Vaccines In 2024 Canberra, Australia2024 [updated 29/2/2024. Available from: https://www.health.gov.au/resources/publications/atagi-statement-on-the-administration-of-covid-19-vaccines-in-2024?language=en.

Vergori A, Cozzi Lepri A, Cicalini S, Matusali G, Bordoni V, Lanini S, et al. Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV. Nat Commun. 2022;13(1):4922.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen Y, Freeman JA, Holland J, Naidu K, Solterbeck A, Van Bilsen N, et al. Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion. Blood. 2022;140(25):2709–21.

Article  CAS  PubMed  Google Scholar 

Hall VG, Ferreira VH, Ku T, Ierullo M, Majchrzak-Kita B, Chaparro C, et al. Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med. 2021;385(13):1244–6.

Article  PubMed  Google Scholar 

Karaba AH, Johnston TS, Aytenfisu TY, Akinde O, Eby Y, Ruff JE, et al. A fourth dose of COVID-19 vaccine does not induce neutralization of the Omicron variant among solid organ transplant recipients with suboptimal vaccine response. Transplantation. 2022;106(7):1440.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karaba AH, Zhu X, Liang T, Wang KH, Rittenhouse AG, Akinde O, et al. A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients. Am J Transplant. 2022;22(4):1253–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar D, Ferreira VH, Hall VG, Hu Q, Samson R, Ku T, et al. Neutralization of SARS-CoV-2 variants in transplant recipients after two and three doses of mRNA-1273 vaccine: secondary analysis of a randomized trial. Ann Intern Med. 2022;175(2):226–33.

Article  PubMed  Google Scholar 

Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.

Article  PubMed  PubMed Central  Google Scholar 

Zou J, Kurhade C, Patel S, Kitchin N, Tompkins K, Cutler M, et al. Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine. New England J Med. 2023;388(9):854–7.

Article  Google Scholar 

Lin D-Y, Xu Y, Gu Y, Zeng D, Wheeler B, Young H, et al. Effectiveness of bivalent boosters against severe omicron infection. N Engl J Med. 2023;388(8):764–6.

Article  PubMed